Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 4/2019

01-04-2019 | Letter to the Editor

Secondary diffuse large B cell lymphoma of the central nervous system: retrospective review of case series

Authors: Hammad Tashkandi, Mark L. Cohen, Marta E. Couce

Published in: Annals of Hematology | Issue 4/2019

Login to get access

Excerpt

Dear Editor, …
Literature
1.
O’Neill BP, Vernino S, Dogan A, Giannini C (2007) EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetil. Neuro-Oncology 9(3):364–369CrossRefPubMedPubMedCentral
2.
Evens AM, Choquet S, Kroll-Desrosiers AR, Jagadeesh D, Smith SM, Morschhauser F et al (2013) Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era. Am J Transplant 13(6):1512–1522CrossRefPubMed
3.
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri S, Stein H, Thiele J (2017) WHO classification of tumours of haematopoietic and lymphoid tissues. International Agency for Research on Cancer, Lyon
4.
Wudhikarn K, Bunworasate U, Julamanee J, Lekhakula A, Chuncharunee S, Niparuck P et al (2017) Secondary central nervous system relapse in diffuse large B cell lymphoma in a resource limited country: result from the Thailand nationwide multi-institutional registry. Ann Hematol 96(1):57–64CrossRefPubMed
5.
El-Galaly TC, Cheah CY, Bendtsen MD, Nowakowski GS, Kansara R, Savage KJ et al (2018) Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma. Eur J Cancer 93:57–68CrossRefPubMedPubMedCentral
6.
Kawano N, Ochiai H, Yoshida S, Yamashita K, Shide K, Shimoda H et al (2012) Clinical features and treatment outcomes of isolated secondary central nervous system lymphomas in Miyazaki Prefecture. Int J Clin Oncol 17(4):336–340CrossRefPubMed
7.
DeRosa P, Cappuzzo JM, Sherman JH (2014) Isolated recurrence of secondary CNS lymphoma: case report and literature review. J Neurol Surg Rep 75(1):e154–e159CrossRefPubMedPubMedCentral
8.
Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Müller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103(1):275–282CrossRefPubMed
9.
Camilleri-Broët, Sophie, et al. A uniform activated B-cell–like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases. Blood 107.1 (2006): 190–196
Metadata
Title
Secondary diffuse large B cell lymphoma of the central nervous system: retrospective review of case series
Authors
Hammad Tashkandi
Mark L. Cohen
Marta E. Couce
Publication date
01-04-2019
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 4/2019
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-018-3485-4

Other articles of this Issue 4/2019

Annals of Hematology 4/2019 Go to the issue

Letter to the Editor

A case report of congenital erythropoietic anemia II in China with a novel mutation

Original Article

Oncology nurse phone calls halve the risk of reduced dose intensity of immunochemotherapy: results of the randomized FORTIS study in chronic lymphocytic leukemia.

Original Article

Next-generation sequencing with a 54-gene panel identified unique mutational profile and prognostic markers in Chinese patients with myelofibrosis

Original Article

Cytomegalovirus infection is associated with AML relapse after allo-HSCT: a meta-analysis of observational studies

Original Article

Inhaled steroids associated with decreased macrophage markers in nonasthmatic individuals with sickle cell disease in a randomized trial

Original Article

Cyclosporine levels > 195 μg/L on day 10 post-transplant was associated with significantly reduced acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits